메뉴 건너뛰기




Volumn 51, Issue 10, 2007, Pages 3699-3706

Influence of TEM-1 β-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE TEM 1; CEFDITOREN;

EID: 34948868807     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01530-06     Document Type: Article
Times cited : (8)

References (36)
  • 1
    • 0005673779 scopus 로고    scopus 로고
    • Microbiological assays
    • D. S. Reeves, R. Wise, J. M. Andrews, and L. O. White ed, Oxford University Press, Oxford, United Kingdom
    • Andrews, J. M. 1999. Microbiological assays, p. 35-44. In D. S. Reeves, R. Wise, J. M. Andrews, and L. O. White (ed.), Clinical antimicrobial assays. Oxford University Press, Oxford, United Kingdom.
    • (1999) Clinical antimicrobial assays , pp. 35-44
    • Andrews, J.M.1
  • 2
    • 0036151585 scopus 로고    scopus 로고
    • Antibiotic therapy of community respiratory tract infections: Strategies for optimal outcomes and minimized resistance emergence
    • Ball, P., F. Baquero, O. Cars, T. File, J. Garau, K. Klugman, D. E. Low, E. Rubinstein, R. Wise, et al. 2002. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J. Antimicrob. Chemother. 49:31-40.
    • (2002) J. Antimicrob. Chemother , vol.49 , pp. 31-40
    • Ball, P.1    Baquero, F.2    Cars, O.3    File, T.4    Garau, J.5    Klugman, K.6    Low, D.E.7    Rubinstein, E.8    Wise, R.9
  • 3
    • 0021832112 scopus 로고
    • In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives
    • Blaser, J. 1985. In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives. J. Antimicrob. Chemother. 15(Suppl. A):125-130.
    • (1985) J. Antimicrob. Chemother , vol.15 , Issue.SUPPL. A , pp. 125-130
    • Blaser, J.1
  • 4
    • 34447104801 scopus 로고    scopus 로고
    • In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in gram-positives
    • Cafini, F., L. Aguilar, N. Gonzalez, M. J. Gimenez, M. Torrico, L. Alou, D. Sevillano, P. Vallejo, and J. Prieto. 2007. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in gram-positives. J. Antimicrob. Chemother. 59:1185-1189.
    • (2007) J. Antimicrob. Chemother , vol.59 , pp. 1185-1189
    • Cafini, F.1    Aguilar, L.2    Gonzalez, N.3    Gimenez, M.J.4    Torrico, M.5    Alou, L.6    Sevillano, D.7    Vallejo, P.8    Prieto, J.9
  • 5
    • 33845918505 scopus 로고    scopus 로고
    • Performance standards for antimicrobial susceptibility testing
    • Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute, Wayne, PA
    • Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. CLSI/NCCLS document M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
    • (2005) fifteenth informational supplement. CLSI/NCCLS document
  • 6
    • 0031952586 scopus 로고    scopus 로고
    • Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
    • Craig, W. A. 1998. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26:1-10.
    • (1998) Clin. Infect. Dis , vol.26 , pp. 1-10
    • Craig, W.A.1
  • 7
    • 0016913384 scopus 로고
    • Significance of serum protein and tissue binding of antimicrobial agents
    • Craig, W. A., and C. M. Kunin. 1976. Significance of serum protein and tissue binding of antimicrobial agents. Annu. Rev. Med. 27:287-300.
    • (1976) Annu. Rev. Med , vol.27 , pp. 287-300
    • Craig, W.A.1    Kunin, C.M.2
  • 8
    • 0035984795 scopus 로고    scopus 로고
    • Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae
    • Dabernat, H., C. Delmas, M. Seguy, R. Pelissier, G. Faucon, S. Bennamani, and C. Pasquier. 2002. Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob. Agents Chemother. 46:2208-2218.
    • (2002) Antimicrob. Agents Chemother , vol.46 , pp. 2208-2218
    • Dabernat, H.1    Delmas, C.2    Seguy, M.3    Pelissier, R.4    Faucon, G.5    Bennamani, S.6    Pasquier, C.7
  • 9
    • 0035136786 scopus 로고    scopus 로고
    • Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy
    • Dagan, R., K. P. Klugman, W. A. Craig, and F. Baquero. 2001. Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J. Antimicrob. Chemother. 47:129-140.
    • (2001) J. Antimicrob. Chemother , vol.47 , pp. 129-140
    • Dagan, R.1    Klugman, K.P.2    Craig, W.A.3    Baquero, F.4
  • 10
    • 34547849666 scopus 로고    scopus 로고
    • Influence of the β-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media
    • Fenoll, A., L. Aguilar, O. Robledo, M. J. Gimenez, D. Tarrago, J. J. Granizo, M. Gimeno, and P. Coronel. 2007. Influence of the β-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. J. Antimicrob. Chemother. 60:323-327.
    • (2007) J. Antimicrob. Chemother , vol.60 , pp. 323-327
    • Fenoll, A.1    Aguilar, L.2    Robledo, O.3    Gimenez, M.J.4    Tarrago, D.5    Granizo, J.J.6    Gimeno, M.7    Coronel, P.8
  • 11
    • 34447256788 scopus 로고    scopus 로고
    • Ampicillin-resistant non-β-lactamase producing Haemophilus influenzae in Spain: Recent emergence of clonal isolates with increased resistance to cefotaxime and Cefixime
    • Garcia-Cobos, S., J. Campos, E. Lázare, F. Román, E. Cercenado, C. García-Rey, M. Pérez-Vázquex, J. Oteo, and F. de Abajo. 2007. Ampicillin-resistant non-β-lactamase producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and Cefixime. Antimicrob. Agents Chemother. 51:2564-2573.
    • (2007) Antimicrob. Agents Chemother , vol.51 , pp. 2564-2573
    • Garcia-Cobos, S.1    Campos, J.2    Lázare, E.3    Román, F.4    Cercenado, E.5    García-Rey, C.6    Pérez-Vázquex, M.7    Oteo, J.8    de Abajo, F.9
  • 12
    • 34347248739 scopus 로고    scopus 로고
    • Influence of Haemophilus influenzae beta-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenicillins and second- and third-generation cephalosporins
    • Garcia-de-Lomas, J., M. Lerma, L. Cebrian, J. L. Juan-Banon, P. Coronel, M. J. Gimenez, and L. Aguilar. 2007. Influence of Haemophilus influenzae beta-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenicillins and second- and third-generation cephalosporins. Int. J. Antimicrob. Agents 30:190-192.
    • (2007) Int. J. Antimicrob. Agents , vol.30 , pp. 190-192
    • Garcia-de-Lomas, J.1    Lerma, M.2    Cebrian, L.3    Juan-Banon, J.L.4    Coronel, P.5    Gimenez, M.J.6    Aguilar, L.7
  • 13
    • 0033288551 scopus 로고    scopus 로고
    • Antimicrobial susceptibility of 1,422 Haemophilus influenzae isolates from respiratory tract infections in Spain: The results of a 1-year (1996-97) multicenter surveillance study
    • Garcia-Rodriguez, J. A., F. Baquero, J. Garcia de Lomas, L. Aguilar, et al. 1999. Antimicrobial susceptibility of 1,422 Haemophilus influenzae isolates from respiratory tract infections in Spain: the results of a 1-year (1996-97) multicenter surveillance study. Infection 27:265-267.
    • (1999) Infection , vol.27 , pp. 265-267
    • Garcia-Rodriguez, J.A.1    Baquero, F.2    Garcia de Lomas, J.3    Aguilar, L.4
  • 14
    • 0027931788 scopus 로고
    • Antibiotic resistance patterns of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis: A prospective study in Murcia, Spain, 1983-1992
    • Gómez, J., J. Ruiz-Gómez, J. L. Hernández- Cardona, M. L. Nuñez, M. Canteras, and M. Valdés. 1994. Antibiotic resistance patterns of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis: a prospective study in Murcia, Spain, 1983-1992. Chemotherapy 40:299-303.
    • (1994) Chemotherapy , vol.40 , pp. 299-303
    • Gómez, J.1    Ruiz-Gómez, J.2    Hernández- Cardona, J.L.3    Nuñez, M.L.4    Canteras, M.5    Valdés, M.6
  • 15
    • 2142767352 scopus 로고    scopus 로고
    • Rapidly increasing prevalence of beta-lactamase-nonproduring, ampiculin-resistant Haemophilus influenzae type b in patients with meningitis
    • Hasegawa, K., N. Chiba, R. Kobayashi, S. Y. Murayama, S. Iwata, K. Sunakawa, and K. Ubukata. 2004. Rapidly increasing prevalence of beta-lactamase-nonproduring, ampiculin-resistant Haemophilus influenzae type b in patients with meningitis. Antimicrob. Agents Chemother. 48:1509-1514.
    • (2004) Antimicrob. Agents Chemother , vol.48 , pp. 1509-1514
    • Hasegawa, K.1    Chiba, N.2    Kobayashi, R.3    Murayama, S.Y.4    Iwata, S.5    Sunakawa, K.6    Ubukata, K.7
  • 17
    • 0032854834 scopus 로고    scopus 로고
    • Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. surveillance study
    • Jacobs, M. R., S. Bajaksouzian, A. Zilles, G. Lin, G. A. Pankuch, and P. C. Appelbaum. 1999. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. surveillance study. Antimicrob. Agents Chemother. 43:1901-1908.
    • (1999) Antimicrob. Agents Chemother , vol.43 , pp. 1901-1908
    • Jacobs, M.R.1    Bajaksouzian, S.2    Zilles, A.3    Lin, G.4    Pankuch, G.A.5    Appelbaum, P.C.6
  • 18
    • 33748687374 scopus 로고    scopus 로고
    • Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae
    • Jansen, W. T., A. Verel, M. Beitsma, J. Verhoef, and D. Milatovic. 2006. Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae. J. Antimicrob. Chemother. 58:873-877.
    • (2006) J. Antimicrob. Chemother , vol.58 , pp. 873-877
    • Jansen, W.T.1    Verel, A.2    Beitsma, M.3    Verhoef, J.4    Milatovic, D.5
  • 19
    • 0035005015 scopus 로고    scopus 로고
    • The clinical pharmacokinetics of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate
    • Kaye, C. M., A. Allen, S. Perry, M. McDonagh, M. Davy, K. Storm, N. Bird, and O. Dewit. 2001. The clinical pharmacokinetics of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate. Clin. Ther. 23:578-584.
    • (2001) Clin. Ther , vol.23 , pp. 578-584
    • Kaye, C.M.1    Allen, A.2    Perry, S.3    McDonagh, M.4    Davy, M.5    Storm, K.6    Bird, N.7    Dewit, O.8
  • 20
    • 0021837433 scopus 로고
    • Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae
    • Lavoie, G. Y., and M. G. Bergeron. 1985. Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae. Antimicrob. Agents Chemother;. 28:404-412.
    • (1985) Antimicrob. Agents Chemother , vol.28 , pp. 404-412
    • Lavoie, G.Y.1    Bergeron, M.G.2
  • 21
    • 0036805581 scopus 로고    scopus 로고
    • Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: A comparison of different dosage regimens including a pharmacokinetically enhanced formulation
    • Lowdin, E., O. Cars, and I. Odenholt. 2002. Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: a comparison of different dosage regimens including a pharmacokinetically enhanced formulation. Clin. Microbiol. Infect;. 8:646-653.
    • (2002) Clin. Microbiol. Infect , vol.8 , pp. 646-653
    • Lowdin, E.1    Cars, O.2    Odenholt, I.3
  • 22
    • 33745586714 scopus 로고    scopus 로고
    • Principles of anti-infective therapy
    • G. L. Mandell, J. E. Bennett, and R. Dolin ed, 6th ed. Elsevier Churchill Livingstone, Philadelphia, PA
    • Moellering, R. C., and G. M. Eliopoulos. 2005. Principles of anti-infective therapy, p. 242-253. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett principles and practice of infectious diseases, 6th ed. Elsevier Churchill Livingstone, Philadelphia, PA.
    • (2005) Mandell, Douglas, and Bennett principles and practice of infectious diseases , pp. 242-253
    • Moellering, R.C.1    Eliopoulos, G.M.2
  • 24
    • 0031049862 scopus 로고    scopus 로고
    • In-vitro pharmacodynamic simulation of clavulanic acid concentrations: Effect on Staphylococcus aureus and Haemophilus influenzae beta-lactamase activity
    • Martin, M., L. Aguilar, I. P. Balcabao, M. L. Gomez-Lus, R. Dal-Re, and J. Prieto. 1997. In-vitro pharmacodynamic simulation of clavulanic acid concentrations: effect on Staphylococcus aureus and Haemophilus influenzae beta-lactamase activity. J. Antimicrob. Chemother. 39:290-292.
    • (1997) J. Antimicrob. Chemother , vol.39 , pp. 290-292
    • Martin, M.1    Aguilar, L.2    Balcabao, I.P.3    Gomez-Lus, M.L.4    Dal-Re, R.5    Prieto, J.6
  • 25
    • 0347519283 scopus 로고    scopus 로고
    • Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanic acid resistance in beta-lactamase- positive, amoxicillin/clavulanic acid-resistant Haemophilus influenzae
    • Matic, V., B. Bozdogan, M. R. Jacobs, K. Ubukata, and P. C. Appelbaum. 2003. Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanic acid resistance in beta-lactamase- positive, amoxicillin/clavulanic acid-resistant Haemophilus influenzae. J. Antimicrob. Chemother. 52:1018-1021.
    • (2003) J. Antimicrob. Chemother , vol.52 , pp. 1018-1021
    • Matic, V.1    Bozdogan, B.2    Jacobs, M.R.3    Ubukata, K.4    Appelbaum, P.C.5
  • 26
    • 34948850637 scopus 로고    scopus 로고
    • Mulford, D., M. Mayer, and G. Witt. 2000. Effect of age and gender on the pharmacokinetics of cefditoren. Abstr. 40th Intersci. Conf. Antimicrob. Agents Chemother. 2000, abstr. 310. American Society for Microbiology, Washington, DC.
    • Mulford, D., M. Mayer, and G. Witt. 2000. Effect of age and gender on the pharmacokinetics of cefditoren. Abstr. 40th Intersci. Conf. Antimicrob. Agents Chemother. 2000, abstr. 310. American Society for Microbiology, Washington, DC.
  • 27
    • 34948877378 scopus 로고    scopus 로고
    • Mulford, D., M. Mayer, and G. Witt. 2000. Effect of renal impairment on the pharmacokinetic of cefditoren. Abstr. 40th Intersci. Conf. Antimicrob. Agents Chemother. 2000, abstr. 311. American Society for Microbiology, Washington, DC.
    • Mulford, D., M. Mayer, and G. Witt. 2000. Effect of renal impairment on the pharmacokinetic of cefditoren. Abstr. 40th Intersci. Conf. Antimicrob. Agents Chemother. 2000, abstr. 311. American Society for Microbiology, Washington, DC.
  • 28
    • 34948877875 scopus 로고    scopus 로고
    • National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that growth aerobically; approved standard, 6th ed. NCCLS M7-A6. NCCLS, Wayne, PA.
    • National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that growth aerobically; approved standard, 6th ed. NCCLS M7-A6. NCCLS, Wayne, PA.
  • 30
    • 0031807596 scopus 로고    scopus 로고
    • In vitro activities of co-amoxiclav at concentrations achieved in human serum against the resistant subpopulation of heteroresistant Staphylococcus aureus: A controlled study with vancomycin
    • Prieto, J., L. Aguilar, M. J. Gimenez, D. Toro, M. L. Gomez-Lus, R. Dal-Re, and I. P. Balcabao. 1998. In vitro activities of co-amoxiclav at concentrations achieved in human serum against the resistant subpopulation of heteroresistant Staphylococcus aureus: a controlled study with vancomycin. Antimicrob. Agents Chemother. 42:1574-1577.
    • (1998) Antimicrob. Agents Chemother , vol.42 , pp. 1574-1577
    • Prieto, J.1    Aguilar, L.2    Gimenez, M.J.3    Toro, D.4    Gomez-Lus, M.L.5    Dal-Re, R.6    Balcabao, I.P.7
  • 32
    • 0032927975 scopus 로고    scopus 로고
    • Increasing prevalence of ampicillin-resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan
    • Seki, H., Y. Kasahara, K. Ohta, Y. Saikawa, R. Sumita, A. Yachie, S. Fujita, and S. Koizumi. 1999. Increasing prevalence of ampicillin-resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan. Chemotherapy 45:15-21.
    • (1999) Chemotherapy , vol.45 , pp. 15-21
    • Seki, H.1    Kasahara, Y.2    Ohta, K.3    Saikawa, Y.4    Sumita, R.5    Yachie, A.6    Fujita, S.7    Koizumi, S.8
  • 33
    • 12344323596 scopus 로고    scopus 로고
    • Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation
    • Sevillano, D., A. Calvo, M. J. Gimenez, L. Alou, L. Aguilar, E. Valero, A. Carcas, and J. Prieto. 2004. Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation. J. Antimicrob. Chemother. 54:1148-1151.
    • (2004) J. Antimicrob. Chemother , vol.54 , pp. 1148-1151
    • Sevillano, D.1    Calvo, A.2    Gimenez, M.J.3    Alou, L.4    Aguilar, L.5    Valero, E.6    Carcas, A.7    Prieto, J.8
  • 35
    • 0034997881 scopus 로고    scopus 로고
    • Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae
    • Ubukata, K., Y. Shibasaki, K. Yamamoto, N. Chiba, K. Hasegawa, Y. Takeuchi, K. Sunakawa, M. Inoue, and M. Konno. 2001. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob. Agents Chemother. 45:1693-1699.
    • (2001) Antimicrob. Agents Chemother , vol.45 , pp. 1693-1699
    • Ubukata, K.1    Shibasaki, Y.2    Yamamoto, K.3    Chiba, N.4    Hasegawa, K.5    Takeuchi, Y.6    Sunakawa, K.7    Inoue, M.8    Konno, M.9
  • 36
    • 9944248106 scopus 로고    scopus 로고
    • Cefditoren pivoxil: A review of its use in the treatment of bacterial infections
    • Wellington, K., and M. P. Curran. 2004. Cefditoren pivoxil: a review of its use in the treatment of bacterial infections. Drugs 64:2597-2618.
    • (2004) Drugs , vol.64 , pp. 2597-2618
    • Wellington, K.1    Curran, M.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.